Stamcelleterapi ved iskæmisk hjertesygdom

Axel Cosmus Pyndt Diederichsen, Jacob Eifer Møller, Malthe A M Kristiansen, Susanne Gjørup Saekmose, Torben Barington, Lars M Videbaek, Moustapha S Kassem, Per Thayssen

    Publikation: Bidrag til tidsskriftReviewForskningpeer review


    Stem cell therapy is a treatment of great potential, including in cardiology. In the past few years, it has been shown that the heart has the potential for regeneration. Clinical studies have shown that intracoronary or intracardiac transplantation of bone marrow stem cells to patients with chronic or acute ischemic heart diseases improves the function and regional myocardial perfusion of the left ventricle. No significant complications have been described. However, since there is no evidence on morbidity or mortality, there is a great need for further research before the treatment can be implemented in the daily clinic.

    Bidragets oversatte titelStem cell therapy in ischemic heart disease
    Sider (fra-til)1111-4
    Antal sider4
    TidsskriftUgeskrift for laeger
    Udgave nummer11
    StatusUdgivet - 13 mar. 2006


    • Bone Marrow Transplantation/adverse effects
    • Clinical Trials as Topic
    • Humans
    • Myocardial Infarction/therapy
    • Myocardial Ischemia/therapy
    • Myocardial Reperfusion
    • Randomized Controlled Trials as Topic
    • Risk Factors
    • Stem Cell Transplantation/adverse effects


    Udforsk hvilke forskningsemner 'Stamcelleterapi ved iskæmisk hjertesygdom' indeholder.